Business Description
Cengild Medical Bhd
ISIN : MYQ0243OO004
Total Employee Number:
151Compare
Compare
Traded in other countries / regions
0243.Malaysia IPO Date
2022-04-18Description
Cengild Medical Bhd is a healthcare service provider operating a medical centre specializing in the diagnosis and treatment of gastrointestinal-related diseases, oncology, gynecology services., liver diseases, and obesity. The company operates in Malaysia and has two reportable segments, Consultant Services and Medical Management Services. A substantial portion of the overall revenue is generated from its Medical Management Services segment.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.64 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.75 | |||||
Debt-to-EBITDA | 4.4 | |||||
Interest Coverage | 63.57 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.97 | |||||
Beneish M-Score | -2.43 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.4 | |||||
3-Year EBITDA Growth Rate | 3.6 | |||||
3-Year EPS without NRI Growth Rate | 4.3 | |||||
3-Year Book Growth Rate | 6.3 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 52.13 | |||||
9-Day RSI | 47.14 | |||||
14-Day RSI | 46.02 | |||||
3-1 Month Momentum % | 2.44 | |||||
6-1 Month Momentum % | -6.67 | |||||
12-1 Month Momentum % | -10.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.93 | |||||
Quick Ratio | 3.81 | |||||
Cash Ratio | 3.23 | |||||
Days Inventory | 19.76 | |||||
Days Sales Outstanding | 40.2 | |||||
Days Payable | 78.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 3.5 | |||||
Dividend Payout Ratio | 0.54 | |||||
Forward Dividend Yield % | 3.3 | |||||
5-Year Yield-on-Cost % | 3.59 | |||||
3-Year Average Share Buyback Ratio | -0.6 | |||||
Shareholder Yield % | -25.31 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 46.4 | |||||
Operating Margin % | 18.25 | |||||
Net Margin % | 12.87 | |||||
EBITDA Margin % | 26.9 | |||||
FCF Margin % | -85.39 | |||||
OCF Margin % | 12.45 | |||||
ROE % | 8.2 | |||||
ROA % | 4.78 | |||||
ROIC % | 9.03 | |||||
3-Year ROIIC % | 3.83 | |||||
ROC (Joel Greenblatt) % | 13.53 | |||||
ROCE % | 7.83 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 16.67 | |||||
PE Ratio without NRI | 15.38 | |||||
PEG Ratio | 1.26 | |||||
PS Ratio | 2.3 | |||||
PB Ratio | 1.44 | |||||
Price-to-Tangible-Book | 1.43 | |||||
Price-to-Operating-Cash-Flow | 18.18 | |||||
EV-to-EBIT | 14.37 | |||||
EV-to-EBITDA | 10.05 | |||||
EV-to-Revenue | 2.7 | |||||
EV-to-FCF | -3.17 | |||||
Price-to-GF-Value | 0.69 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.95 | |||||
Price-to-Graham-Number | 1 | |||||
Earnings Yield (Greenblatt) % | 6.96 | |||||
FCF Yield % | -37.49 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cengild Medical Bhd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil RM) | 73.151 | ||
| EPS (TTM) (RM) | 0.012 | ||
| Beta | -0.4691 | ||
| 3-Year Sharpe Ratio | -1.35 | ||
| 3-Year Sortino Ratio | -1.46 | ||
| Volatility % | 19.82 | ||
| 14-Day RSI | 46.02 | ||
| 14-Day ATR (RM) | 0.005944 | ||
| 20-Day SMA (RM) | 0.2015 | ||
| 12-1 Month Momentum % | -10.64 | ||
| 52-Week Range (RM) | 0.195 - 0.275 | ||
| Shares Outstanding (Mil) | 832.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cengild Medical Bhd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cengild Medical Bhd Stock Events
| Event | Date | Price (RM) | ||
|---|---|---|---|---|
| MYR 0.003300 Cash Dividend | 2026-02-25 | 0.23 (+0.00%) | ||
| MYR 0.003700 Cash Dividend | 2025-09-18 | 0.23 (+0.00%) | ||
| MYR 0.006000 Cash Dividend | 2025-02-12 | 0.29 (+0.00%) | ||
| MYR 0.003700 Cash Dividend | 2024-09-10 | 0.28 (-1.79%) |
Show
Entries
Cengild Medical Bhd Frequently Asked Questions
What is Cengild Medical Bhd(XKLS:0243)'s stock price today?
The current price of XKLS:0243 is RM0.20. The 52 week high of XKLS:0243 is RM0.28 and 52 week low is RM0.20.
When is next earnings date of Cengild Medical Bhd(XKLS:0243)?
The next earnings date of Cengild Medical Bhd(XKLS:0243) is .
Does Cengild Medical Bhd(XKLS:0243) pay dividends? If so, how much?
The Dividend Yield %  of Cengild Medical Bhd(XKLS:0243) is 3.5% (As of Today), Highest Dividend Payout Ratio of Cengild Medical Bhd(XKLS:0243) was 0.59. The lowest was 0.44. And the median was 0.5. The  Forward Dividend Yield % of Cengild Medical Bhd(XKLS:0243) is 3.3%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Cengild Medical Bhd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers